Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.29 USD | -1.69% | +2.81% | +19.83% |
May. 22 | Halozyme Therapeutics Insider Sold Shares Worth $905,480, According to a Recent SEC Filing | MT |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
Financials (USD)
Sales 2024 * | 951M | Sales 2025 * | 1.1B | Capitalization | 5.64B |
---|---|---|---|---|---|
Net income 2024 * | 373M | Net income 2025 * | 466M | EV / Sales 2024 * | 6.88 x |
Net Debt 2024 * | 899M | Net Debt 2025 * | 422M | EV / Sales 2025 * | 5.53 x |
P/E ratio 2024 * |
14.6
x | P/E ratio 2025 * |
11.5
x | Employees | 373 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.89% |
Latest transcript on Halozyme Therapeutics, Inc.
1 day | -1.69% | ||
1 week | +2.81% | ||
1 month | +10.97% | ||
3 months | +8.21% | ||
6 months | +10.42% | ||
Current year | +19.83% |
Managers | Title | Age | Since |
---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 61 | 14-01-05 |
Nicole LaBrosse
DFI | Director of Finance/CFO | 41 | 14-12-31 |
Mark Snyder
CMP | Compliance Officer | 57 | 22-01-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
BRD | Director/Board Member | 70 | 06-07-30 |
Chairman | 59 | 15-08-04 | |
Barbara Duncan
BRD | Director/Board Member | 59 | 23-02-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.48% | 5 M€ | -1.80% | - | |
0.73% | 0 M€ | 0.00% | - | |
0.55% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 44.3 | -1.66% | 675,455 |
24-06-03 | 45.05 | +1.72% | 1,082,426 |
24-05-31 | 44.29 | +2.17% | 1,182,236 |
24-05-30 | 43.35 | +1.38% | 868,001 |
24-05-29 | 42.76 | -0.74% | 1,102,023 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.83% | 5.73B | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- HALO Stock